摘要
新型冠状病毒肺炎暴发以来,四川省人民医院药学部结合《新型冠状病毒感染的肺炎诊疗方案》,制定洛匹那韦/利托那韦和α-干扰素等抗病毒药物的合理使用与药学监护要点,指导临床合理用药。该文总结报道上述工作,以期为其他医疗机构的新型冠状病毒肺炎诊疗及合理用药提供参考。
Since the outbreak of Corona Virus Disease 2019, the department of pharmacy of Sichuan Provincial People’s Hospital has formulated the rational use and pharmaceutical care of antiviral drugs such as lopinavir/ritonavir and α-interferon with the diagnosis and treatment schemefor Corona Virus Disease 2019 released by the National Health Commission as reference to guide the rational use of drugs in clinic.This paper summarizes the above work in order to provide reference for the diagnosis and treatment of Corona Virus Disease 2019 and rational use of drugs in other medical institutions.
作者
边原
王玥媛
杨勇
舒永全
熊堉
童荣生
闫峻峰
何林
龙恩武
陈岷
刘心霞
BIAN Yuan;WANG Yueyuan;YANG Yong;SHU Yongquan;XIONG Yu;TONG Rongsheng;YAN Junfeng;HE Lin;LONG Enwu;CHEN Min;LIU Xinxia(Personalized Drug Therapy Key Laboratory of Sichuan Province,Department of Pharmacy,Sichuan Academy of Medical Sciences,Sichuan Provincial People’s Hospital,Affiliated Hospital of University of Electronic Science and Technology of China,Chengdu 610072,China;School of Medicine,University of Electronic Science and Technology of China,Chengdu 610054,China)
出处
《医药导报》
CAS
北大核心
2020年第3期338-345,共8页
Herald of Medicine
基金
国家临床重点专科建设项目(30305030698)
四川省省级公益性科研院所基本科研业务专项课题(2018YSKY0017)
四川省人民医院院级科研基金临床研究及转化项目(2018LY09)。
关键词
临床药师
新型冠状病毒肺炎
抗病毒药物
合理用药
药学监护
Pharmacist
Corona Virus Disease 2019(COVID-19)
Antiviral drugs
Rational Use
Pharmaceutical Care
